Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-25T17:55:38.934Z Has data issue: false hasContentIssue false
  • English
  • Français

Análisis de componentes principales de la PANSS y la SANS-SAPS en esquizofrenia: su estabilidad en una fase aguda

Published online by Cambridge University Press:  12 May 2020

S. Dollfus  and
M. Petit
S. Dollfus
Affiliation:
Departamento de Psiquiatría, Centro Esquirol, CHU Côte de Nacre, Caen, Francia
M. Petit
Affiliation:
Departamento de Psiquiatría, Universidad de Rouen, Centro Hospitalario de Rouvray, Sotteville-les-Rouen, Francia
Get access

Abstract

Se pongan de acuerdo o no los estudios sobre la dicotomía positivo-negativo en esquizofrenia, la pertinencia de un tercer componente, la desorganización, es una cuestión polémica. La desorganización, expresada por los análisis de componentes principales de la Escala para la Evaluación de Síntomas Negativos y Síntomas Positivos (SANS-SAPS) y la Escala del Síndrome Positivo y Negativo (PANSS), se podría considerar como una dimensión tan permanente y determinante como los componentes positivo y negativo. Por tanto, el propósito del presente estudio era determinar si esta desorganización, junto con los componentes positivo y negativo, es estable y tiene la misma composición en las fases aguda y post-aguda de la enfermedad. Este estudio se llevó a cabo en 57 pacientes, definidos de manera general al menos por uno de cuatro criterios diagnósticos (American Psychiatric Association, Langfeldt, Carpenter y Schneider), establecidos con una lista informatizada y valorados con la SANS-SAPS y la PANSS. Se realizaron análisis de componentes principales (ACP) de estas escalas en la admisión y el alta del hospital.

El ACP de la SANS-SAPS mostró una solución de tres factores, sin variación por la fase de la enfermedad (aguda o postaguda), mostrando que los componentes negativo, positivo y de desorganización eran estables. El ACP de la PANSS produjo componentes negativo y positivo completamente estables en el tiempo y un componente de desorganización cuya composición variaba entre la admisión y el alta. En la admisión, incluía el elemento de desorganización conceptual, correlacionado negativamente con uno de depresión. En el alta, este componente incluía dos apartados adicionales, preocupación autista y manerismos, y aparecía un componente de depresión. La inestabilidad del ACP de la PANSS podría expresar el papel desempeñado por la fase de la enfermedad: en una fase aguda, el componente de desorganización estaba constituido por más elementos “positivos”, como grandiosidad, contenido inusual del pensamiento y evitación social activa, mientras que en la fase post-aguda, incluía elementos que reflejaban más la cronicidad de la enfermedad, como amaneramientos y preocupación autista. Por otra parte, en la fase post-aguda aparecía el elemento depresivo en un componente depresivo específico. Este resultado se podría deber al hecho de que los síntomas depresivos no se pueden expresar cuando los síntomas positivos son muy graves, lo que explica por qué no se mostraban componentes depresivos durante la fase aguda.

Keywords

síntomas negativos y positivosdimensión de desorganizaciónanálisis de componentes principalesseguimientoesquizofrenia
Type
Artículo original
Information
European Psychiatry (Ed. Española) , Volume 2 , Issue 4 , August 1995 , pp. 219 - 230
Copyright
Copyright © European Psychiatric Association 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

Addington, J, Addington, D. Positive and negative symptoms of schizophrenia. Their course and relationship over time. Schizophren Res 1991; 5: 51–9.CrossRefGoogle ScholarPubMed
American Psychiatric Association. Diagnostic and Statisiic Manual of Mental Disorders (DSMIII-R), Washington 1987. Traduction frangaise: Manuel diagnostique et statistique des troubles mentaux. Paris: Masson, 1989; 624.Google Scholar
Andreasen, NC, Grove, WN. Evaluation of positive and negative symptoms in schizophrenia. Psychiatry Psychobiol 1986; 1,2: 108–21.Google Scholar
Andreasen, NC, Olsen, S. Negative versus positive schizophrenia. Arch Gen Psychiatry 1982; 39: 789–94.CrossRefGoogle Scholar
Arndt, S, Alliger, RJ, Andreasen, NC. The distinction of postivie and negative symptoms. The failure of a two-dimensional Model. Br J Psychiatry 1991; 158: 317–22.CrossRefGoogle Scholar
Ban, TA. Drug treatment in schizophrenia. Cañad Psychiatr Ass J 1971; 16: 473–85.Google Scholar
Bell, MD, Lysaker, PH, Milstein, RM, Beam-Goulet, JL. Five factor model of schizophrenia: replication of PANSS factor structure and implications for subtyping. 145tgh Annual Meeting of the American Psychiatric Association. Washington, D.C., May 1992.Google Scholar
Bilder, RM, Mukherjee, S, Rieder, RO, Pandurangi, AK. Symptomatic and neuropsychological components of defect States. Schizophren Bull 1985; 11: 409–19.CrossRefGoogle ScholarPubMed
Boyer, P, Lecrubier, Y. Fiche descriptive et traduction française de la SAPS. Psychiatr Psychobiol 1987; 11,6: 425–37.Google Scholar
Boyer, P, Lecrubier, Y, Puech, AJ. Treatment of positive and negative symptoms: pharmacologic approaches. In: Andreasen, N, ed. Schizophrenia: positive and negative symptoms and syndromes: Modern Problems of Pharmacopsychiatry. Basel: Karger, 1990; 24: 152–74.Google Scholar
Carmines, EG, Zeller, A. Reliability and validity assessment. In: Sullivan, JL, ed. Quantitative applications in the social Sciences. Beverly Hills: Sage publication, 1979.Google Scholar
Carpenter, WT, Strauss, JS, Bartko, JJ. Flexible system for diagnosis of schizophrenia: Report from the WHO international pilot study of schizophrenia. Science 1973; 182: 1275–78.CrossRefGoogle ScholarPubMed
Chaslin Ph. Groupe provisoire des folies discordantes. In: Asselin et Houzeau, eds. Éléments de sémiologie et clinique mentales. Paris, 1912.Google Scholar
Cornblatt, BA, Lenzenweger, MF, Dworkin, RH, Erlenmeyer-Kimling, L. Positive and negative schizophrenic symptoms, attention, and information Processing. Schizophr Bull 1985; 11,3: 397–406.CrossRefGoogle ScholarPubMed
Crow, TJ. Molecular pathology of schizophrenia: more than one disease process. Br J Psychiatry 1980; 280: 66–8.Google ScholarPubMed
De Bonis, M, Boek, P, Lebeaux, MO . Methodological problems in subtyping schizophrenics: correlations versus hierarchical relationships. Psychiatry Psychobiol 1987; 11,6: 425–37.Google Scholar
Diagnostic and statistical manual of mental disorders. Third edition, revised (DSMIII-R). American Psychiatric Association, Washington D.C., 1987. Traduction frangaise: Manuel diagnostique et statistique des troubles mentaux. Paris: Masson, 1989; 624.Google Scholar
Dollfus, S, Petit, M, Lesieur, Ph, Menard, JF. Principal components analyses of PANSS and SAPS-SANS in schizophrenia. Eur Psychiatry 1991; 6: 251–9.Google Scholar
Dollfus, S, Petit, M, Menard, JF, Brazo, P, Besse-Assouly, F, Preterre, Ph, Lesieur, Ph. Polydiagnostic approach of schizophrenia: validity of a Computer checklist (LIDE). Encephale, 1994; XX: 91–101.Google Scholar
Dollfus, S, Petit, M, Menard, JF, Lesieur, Ph. Schizophrenia: comparison of 13 diagnostic Systems in a cross-sectional study. Eur Psychiatry 1993a; 8: 7–13.Google Scholar
Dollfus, S, Petit, M, Menard, JF. Relationship between depressive and positive symptoms in schizophrenia. J Affective Disord 1993b; 28: 61–9.CrossRefGoogle Scholar
Endicott, J, Nee, J, Cohén, J, Fleiss, JL, Simon, R. Diagnosis of schizophrenia. Arch Gen Psychiatry 1986; 43: 13–9.CrossRefGoogle ScholarPubMed
Foster, P. Neuroleptic equivalence. Pharm J 1989; 30: 431–2.Google Scholar
Frangos, H, Zissis, NP, Leontopoulos, I , Diamantas, N, Tsitouridis, S, Gavril, I, Tsolis, K. Double blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenic. Acta Psychiatr Scand 1978; 57: 436–46.CrossRefGoogle Scholar
Gibbons, RD, Lewine, RRJ, Davis, JM, Schooler, NR, Cole, JO. An empirical test of a Kraepelinian vs a Bleulerian view of negative symptoms. Schizophr Bull 1985; 11: 390–6.CrossRefGoogle Scholar
Golberg, SC. Negative and déficit symptoms in schizophrenia do respond to neuroleptics? Schizophren Bull 1985; 11,3: 453–6.CrossRefGoogle Scholar
Gur, RE, Mozley, PD, Resnick, SM, Levick, S, Erwin, R, Saykin, AJ, Gur, RC. Relations among clinical scale in schizophrenia. Am JPsychiatry 1991; 148: 472–8.Google Scholar
Helzer, JE, Brockington, IF, Kendell, RE. Predictive .validity of DSMIII and Feighner definitions of schizophrenia. Arch Gen Psychiatry 1981; 38: 791–7.Google Scholar
Kane, JM, Honigfeld, G, Singer, J, Meltzer, A. Clozapine in treatment resistant schizophrenia. Arch Gen Psychiatry 1988; 45: 789–95.CrossRefGoogle Scholar
Kayne, JM. Mayerhoff, D. Do negative symptoms respond to pharmacological treatment? Br J Psychiatry 1989; 155 (suppl 7): 115-8.Google Scholar
Kay, SR, Fiszbein, A, Lindenmayer, JP, Opler, LA. Positive and negative syndromes in schizophrenia as a function of chronicity. Acta Psychiatr Scand 1986; 74: 507–18.CrossRefGoogle ScholarPubMed
Kay, SR, Fiszbein, A, Opler, LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophren Bull 1987; 13: 261–76.CrossRefGoogle Scholar
Kay, SR, Sevy, S. Pyramidical model of schizophrenia. Schizophren Bull 1990; 16: 537–45.Google ScholarPubMed
Kay, SR, Singh, MM. The positive-negative distinction in drugfree schizophrenic patients. Arch Gen Psychiatry 1989; 46: 711–8.CrossRefGoogle Scholar
Knights, A, Hirsch, SR. Revealed depression and drug treatment for schizophrenia. Arch Gen Psychiatry 1981; 38: 806–11.CrossRefGoogle Scholar
Kulhara, P, Chandiramani, K. Positive and negative subtypes of schizphrenia; a follow-up study from India. Schizophr Res 1990; 3: 107–16.CrossRefGoogle Scholar
Kulhara, P, Kota, SK, Joseph, S. Positive and negative subtypes of schizophrenia a study from India. Acta Psychiat Scand 1986; 74: 353–9.CrossRefGoogle ScholarPubMed
Langfeldt, G. Diagnosis and prognosis of schizophrenia. Proc Roy Soc Med 1960; 53: 1047–52.CrossRefGoogle ScholarPubMed
Lapierre, YDLavallée, J.Pimozide and the social behavior of schizophrenics. Curr TherRes 1975; 18,1: 181–8.Google ScholarPubMed
Lecrubier, Y, Boyer, P. Fiche descriptive et traduction francaise de la SANS. Psychiatr Psychobiol 1987; 11,6: 414–24.Google Scholar
Lepine, JP, Piron, JJ, Chapotot, E. Factor analysis of PANSS in schizophrenia patients.In: Stefanis, CN, Soldatos, CR, Rabavilas, AD, eds. Psychiatry today: Accomplishments and promises. Amsterdam: Excerpta Medica, 1989.Google Scholar
Lewine, RRJ, Fogg, L, Meltzer, HY. Assessment of negative and positive symptoms in schizophrenia. Schizophren Bull 1983; 9,3: 368–76.CrossRefGoogle Scholar
Liddle, PF. The symptoms of chronic schizophrenia. A re-examination of the positive negative dichotomy. Br J Psychiatry 1987; 151: 145–51.Google ScholarPubMed
Liddle, PF. Barnes, TRE, Morris, D, Haque, S. Three syndromes in chonic schizophrenia. Br J Psychiatry 1989; 155 (suppl 7): 119–22.CrossRefGoogle Scholar
Lindenmayer, JP, Hyman, RB, Grochowski, S. Five factor model of schizophrenia: initial validation. J Nerv Ment Dis 1994; 182: 631–8.CrossRefGoogle ScholarPubMed
McGlashan, TH. Testing four diagnostic systems for schizophrenia. Arch Gen Psychiatry 1984; 41: 141–4.Google Scholar
Moorey, S, Greer, S, Watson, M, Gorman, C, Rowden, L. Tummore R, Robertson B, Bliss J. The factor structure and factor stability of the hospital anxiety and depression scale in patients with cáncer. Br J Psychiatry 1991; 158: 255–9.CrossRefGoogle Scholar
Mortimer, AM, Lund, CE, McKenna, PJ. The positive: negative dichotomy in schizophrenia. Br J Psychiatry 1990; 157: 41–9.CrossRefGoogle Scholar
Mueser, KT, Douglas, MS, Bellack, AS, Morrison, RL. Assessment of enduring déficit and negative symptom subtypes in schizophrenia. Schizophr Bull 1991; 17,4: 565–82.CrossRefGoogle Scholar
Opler, LA, Katy, SR, Rosado, V, Lindenmayer, JP. Positive and negative syndromes in chronic schizophrenic inpatients. J Nerv and Ment Dis 1984; 172,6: 317–25.CrossRefGoogle ScholarPubMed
Peralta, V, de León, J, Cuesta, MJ. Are there more than two syndromes in schizophrenia? A critique of thepositive-negative dichotomy. Br J Psychiatry 1992; 161: 335–43.CrossRefGoogle ScholarPubMed
Petit, M. Zann, M, Lesieur, Ph, Colonna, L. The effect of sulpiride on negative symptoms of schizophrenia. Br J Psychiatry 1987; 150: 270.CrossRefGoogle ScholarPubMed
Phillips, MR, Zhao, Z, Wxiong, X, Cheng, X, Sun, G, Wu, N. Changes in the positive and negative symptoms of schizophrenic in-patients in China. Br J Psychiatry 1991; 159: 226–31.CrossRefGoogle ScholarPubMed
Poirier-Littré, MF, Galinowski, A, Peron-Magnan, P, Vanelle, JM, Raffaitin, F, Piron, JJ, Piketti, M, Loo Bipolar effect of pipotiazine according to dosage in negative and positive forms of schizophrenia. VIII World Congress of Psychiatry, Athenes, 1989; abstract: 661.Google Scholar
Puli, MC, Puli, CM, Pichot, P. Des critères empiriques français pour les psychoses. II. Consensus des psychiatres français et définitions provisoires. Enchephale 1987a; XIII: 53–7.Google Scholar
Puli, CB, Puli, CM, Pichot, P. LICET-S: une liste intégrée de critères d’évaluation taxinomiques pour les psychoses nonaffectives. J Psy Biol Therap 1981; 1: 33–7.Google Scholar
Puli, MC, Puli, CB, Pichot, P. Des critères empiriques français pour les psychoses. III. Algorythmes et arbre de décision. Encephale 1987b; 59-66.Google Scholar
Reuchlin, M.Précis de statistique. 4th ed. Paris: Presses Universitaires de France (PUF), 1987. Risperidone Study Group.Risperidone in the treatment of schizophrenia: a double-blind placebo and controlled active trial. Titusville, New Jersey: Janssen Research Foundation, 1992.Google Scholar
Rosen, WG, Mohs, RC, Johns, CA, Small, NS, Kendler, KS, Horvath, TB, Davis, KL. Positive and negative symptoms in schizophrenia. Psychiatry Res 1984; 13: 277–84.CrossRefGoogle Scholar
Schneider, K. Clinical psychopathology. New York: Gruñe and Stratton, 1959.Google Scholar
Stephens, JH, Astrup, C, Carpenter, WT, Shaffer, JW, Goldberg, JA. Comparison of nine Systems to diagnose schizophrenia. Psychiatry Res 1982; 6: 127–43.Google Scholar
Strauss, JS, Carpenter, WT, Bartko, JJ. The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophren Bull 1974; 11: 61–9.Google Scholar
Tandon, R, Goldman, RS, Goodson, J, Greden, JF. Mutability and relationship between positive and negative symptoms during neuroleptic treatment in schizophrenia. Biol Psychiatry 1990; 27: 1323–6.CrossRefGoogle Scholar
White, L, Parrella, M, Harvey, P, Powchik, P, Davidson, M. PANSS structure in adult and geriatric schizophrenia. New Research Presentation. Annual Conference of the American Psychiatric Association. Washington, D.C., May 1992.Google Scholar